Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
5000
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
HIV Seronegativity
Interventions
BIOLOGICAL:
MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
Sponsor
VaxGen